Interestingly, despite this implication of TACSTD2 in pluripotency and contemporary knowledge that TACSTD2high basal cells efficiently form spheres in vitro, the role of TACSTD2 in prostate cancerization and therapy response is under-explored or, rather, unclear. This evidence concerns the gene TACSTD2 and prostate carcinoma.